ESSILORLUXOTTICA (1EL.MI) Fundamental Analysis & Valuation

BIT:1EL • FR0000121667

216 EUR
+0.6 (+0.28%)
Last: Mar 5, 2026, 07:00 PM

This 1EL.MI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

5

1EL gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 63 industry peers in the Health Care Equipment & Supplies industry. 1EL has an average financial health and profitability rating. 1EL is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

5

1. 1EL.MI Profitability Analysis

1.1 Basic Checks

  • 1EL had positive earnings in the past year.
  • 1EL had a positive operating cash flow in the past year.
  • Each year in the past 5 years 1EL has been profitable.
  • Each year in the past 5 years 1EL had a positive operating cash flow.
1EL.MI Yearly Net Income VS EBIT VS OCF VS FCF1EL.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B 5B

1.2 Ratios

  • The Return On Assets of 1EL (3.62%) is comparable to the rest of the industry.
  • 1EL has a Return On Equity of 5.95%. This is comparable to the rest of the industry: 1EL outperforms 44.44% of its industry peers.
  • The Return On Invested Capital of 1EL (4.96%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA 3.62%
ROE 5.95%
ROIC 4.96%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1EL.MI Yearly ROA, ROE, ROIC1EL.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15

1.3 Margins

  • The Profit Margin of 1EL (8.13%) is comparable to the rest of the industry.
  • 1EL's Profit Margin has improved in the last couple of years.
  • The Operating Margin of 1EL (11.85%) is comparable to the rest of the industry.
  • In the last couple of years the Operating Margin of 1EL has grown nicely.
  • 1EL has a Gross Margin (59.69%) which is comparable to the rest of the industry.
  • 1EL's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 11.85%
PM (TTM) 8.13%
GM 59.69%
OM growth 3Y-2.08%
OM growth 5Y30.97%
PM growth 3Y-2.57%
PM growth 5Y69.02%
GM growth 3Y-1.64%
GM growth 5Y0.64%
1EL.MI Yearly Profit, Operating, Gross Margins1EL.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

4

2. 1EL.MI Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so 1EL is destroying value.
  • There is no outstanding debt for 1EL. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
1EL.MI Yearly Shares Outstanding1EL.MI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M
1EL.MI Yearly Total Debt VS Total Assets1EL.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B

2.2 Solvency

  • An Altman-Z score of 3.11 indicates that 1EL is not in any danger for bankruptcy at the moment.
  • 1EL has a Altman-Z score of 3.11. This is in the better half of the industry: 1EL outperforms 63.49% of its industry peers.
  • 1EL has a debt to FCF ratio of 3.82. This is a good value and a sign of high solvency as 1EL would need 3.82 years to pay back of all of its debts.
  • 1EL has a Debt to FCF ratio of 3.82. This is in the better half of the industry: 1EL outperforms 61.90% of its industry peers.
  • A Debt/Equity ratio of 0.24 indicates that 1EL is not too dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.24, 1EL is in the better half of the industry, outperforming 63.49% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.24
Debt/FCF 3.82
Altman-Z 3.11
ROIC/WACC0.63
WACC7.9%
1EL.MI Yearly LT Debt VS Equity VS FCF1EL.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B 40B

2.3 Liquidity

  • A Current Ratio of 0.99 indicates that 1EL may have some problems paying its short term obligations.
  • Looking at the Current ratio, with a value of 0.99, 1EL is doing worse than 82.54% of the companies in the same industry.
  • A Quick Ratio of 0.70 indicates that 1EL may have some problems paying its short term obligations.
  • With a Quick ratio value of 0.70, 1EL is not doing good in the industry: 77.78% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.99
Quick Ratio 0.7
1EL.MI Yearly Current Assets VS Current Liabilites1EL.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

6

3. 1EL.MI Growth Analysis

3.1 Past

  • The Earnings Per Share has been growing slightly by 0.90% over the past year.
  • The Earnings Per Share has been growing by 30.65% on average over the past years. This is a very strong growth
  • 1EL shows a small growth in Revenue. In the last year, the Revenue has grown by 7.48%.
  • The Revenue has been growing by 14.58% on average over the past years. This is quite good.
EPS 1Y (TTM)0.9%
EPS 3Y2.19%
EPS 5Y30.65%
EPS Q2Q%-0.64%
Revenue 1Y (TTM)7.48%
Revenue growth 3Y5.17%
Revenue growth 5Y14.58%
Sales Q2Q%9.45%

3.2 Future

  • 1EL is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 13.89% yearly.
  • The Revenue is expected to grow by 8.09% on average over the next years. This is quite good.
EPS Next Y17.32%
EPS Next 2Y16.06%
EPS Next 3Y13.67%
EPS Next 5Y13.89%
Revenue Next Year11.54%
Revenue Next 2Y11.17%
Revenue Next 3Y10.73%
Revenue Next 5Y8.09%

3.3 Evolution

  • The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
1EL.MI Yearly Revenue VS Estimates1EL.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 10B 20B 30B 40B
1EL.MI Yearly EPS VS Estimates1EL.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2 4 6 8 10

2

4. 1EL.MI Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 31.53 indicates a quite expensive valuation of 1EL.
  • Compared to the rest of the industry, the Price/Earnings ratio of 1EL is on the same level as its industry peers.
  • When comparing the Price/Earnings ratio of 1EL to the average of the S&P500 Index (26.74), we can say 1EL is valued inline with the index average.
  • The Price/Forward Earnings ratio is 26.87, which means the current valuation is very expensive for 1EL.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of 1EL indicates a slightly more expensive valuation: 1EL is more expensive than 61.90% of the companies listed in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 24.82, 1EL is valued at the same level.
Industry RankSector Rank
PE 31.53
Fwd PE 26.87
1EL.MI Price Earnings VS Forward Price Earnings1EL.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • 1EL's Enterprise Value to EBITDA is on the same level as the industry average.
  • Based on the Price/Free Cash Flow ratio, 1EL is valued a bit cheaper than 61.90% of the companies in the same industry.
Industry RankSector Rank
P/FCF 26.57
EV/EBITDA 17.35
1EL.MI Per share data1EL.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60 80

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates 1EL does not grow enough to justify the current Price/Earnings ratio.
  • A more expensive valuation may be justified as 1EL's earnings are expected to grow with 13.67% in the coming years.
PEG (NY)1.82
PEG (5Y)1.03
EPS Next 2Y16.06%
EPS Next 3Y13.67%

6

5. 1EL.MI Dividend Analysis

5.1 Amount

  • 1EL has a Yearly Dividend Yield of 1.67%. Purely for dividend investing, there may be better candidates out there.
  • The stock price of 1EL dropped by -27.87% in the last 3 months. With lower prices the dividend yield is higher, but it may be a sign investors do not trust the long term dividend.
  • 1EL's Dividend Yield is a higher than the industry average which is at 1.06.
  • 1EL's Dividend Yield is comparable with the S&P500 average which is at 1.82.
Industry RankSector Rank
Dividend Yield 1.67%

5.2 History

  • The dividend of 1EL has a limited annual growth rate of 4.50%.
Dividend Growth(5Y)4.5%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

  • 23.63% of the earnings are spent on dividend by 1EL. This is a low number and sustainable payout ratio.
  • The dividend of 1EL is growing, but earnings are growing more, so the dividend growth is sustainable.
DP23.63%
EPS Next 2Y16.06%
EPS Next 3Y13.67%
1EL.MI Yearly Income VS Free CF VS Dividend1EL.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B
1EL.MI Dividend Payout.1EL.MI Dividend Payout, showing the Payout Ratio.1EL.MI Dividend Payout.PayoutRetained Earnings

1EL.MI Fundamentals: All Metrics, Ratios and Statistics

ESSILORLUXOTTICA

BIT:1EL (3/5/2026, 7:00:00 PM)

216

+0.6 (+0.28%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-11
Earnings (Next)04-22
Inst Owners28.97%
Inst Owner ChangeN/A
Ins Owners32.07%
Ins Owner ChangeN/A
Market Cap100.07B
Revenue(TTM)28.49B
Net Income(TTM)2.31B
Analysts85.16
Price Target330.67 (53.09%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.67%
Yearly Dividend2.56
Dividend Growth(5Y)4.5%
DP23.63%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.2%
PT rev (3m)2.27%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-1.12%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)3.75%
Revenue NY rev (3m)5.04%
Valuation
Industry RankSector Rank
PE 31.53
Fwd PE 26.87
P/S 3.51
P/FCF 26.57
P/OCF 18.91
P/B 2.57
P/tB N/A
EV/EBITDA 17.35
EPS(TTM)6.85
EY3.17%
EPS(NY)8.04
Fwd EY3.72%
FCF(TTM)8.13
FCFY3.76%
OCF(TTM)11.42
OCFY5.29%
SpS61.5
BVpS83.94
TBVpS-4.05
PEG (NY)1.82
PEG (5Y)1.03
Graham Number113.74
Profitability
Industry RankSector Rank
ROA 3.62%
ROE 5.95%
ROCE 6.52%
ROIC 4.96%
ROICexc 5.33%
ROICexgc 34.55%
OM 11.85%
PM (TTM) 8.13%
GM 59.69%
FCFM 13.22%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-2.08%
OM growth 5Y30.97%
PM growth 3Y-2.57%
PM growth 5Y69.02%
GM growth 3Y-1.64%
GM growth 5Y0.64%
F-Score7
Asset Turnover0.45
Health
Industry RankSector Rank
Debt/Equity 0.24
Debt/FCF 3.82
Debt/EBITDA 1.46
Cap/Depr 48.99%
Cap/Sales 5.35%
Interest Coverage 250
Cash Conversion 81.55%
Profit Quality 162.68%
Current Ratio 0.99
Quick Ratio 0.7
Altman-Z 3.11
F-Score7
WACC7.9%
ROIC/WACC0.63
Cap/Depr(3y)49.88%
Cap/Depr(5y)48.88%
Cap/Sales(3y)5.71%
Cap/Sales(5y)5.75%
Profit Quality(3y)150.08%
Profit Quality(5y)168.44%
High Growth Momentum
Growth
EPS 1Y (TTM)0.9%
EPS 3Y2.19%
EPS 5Y30.65%
EPS Q2Q%-0.64%
EPS Next Y17.32%
EPS Next 2Y16.06%
EPS Next 3Y13.67%
EPS Next 5Y13.89%
Revenue 1Y (TTM)7.48%
Revenue growth 3Y5.17%
Revenue growth 5Y14.58%
Sales Q2Q%9.45%
Revenue Next Year11.54%
Revenue Next 2Y11.17%
Revenue Next 3Y10.73%
Revenue Next 5Y8.09%
EBIT growth 1Y-2.12%
EBIT growth 3Y2.98%
EBIT growth 5Y50.07%
EBIT Next Year73.26%
EBIT Next 3Y27.8%
EBIT Next 5Y18.52%
FCF growth 1Y12.35%
FCF growth 3Y5.46%
FCF growth 5Y10.35%
OCF growth 1Y8.56%
OCF growth 3Y3.42%
OCF growth 5Y12.38%

ESSILORLUXOTTICA / 1EL.MI FAQ

What is the fundamental rating for 1EL stock?

ChartMill assigns a fundamental rating of 5 / 10 to 1EL.MI.


Can you provide the valuation status for ESSILORLUXOTTICA?

ChartMill assigns a valuation rating of 2 / 10 to ESSILORLUXOTTICA (1EL.MI). This can be considered as Overvalued.


What is the profitability of 1EL stock?

ESSILORLUXOTTICA (1EL.MI) has a profitability rating of 5 / 10.


What is the financial health of ESSILORLUXOTTICA (1EL.MI) stock?

The financial health rating of ESSILORLUXOTTICA (1EL.MI) is 4 / 10.


Can you provide the expected EPS growth for 1EL stock?

The Earnings per Share (EPS) of ESSILORLUXOTTICA (1EL.MI) is expected to grow by 17.32% in the next year.